---
sidebar_position: 122
---
           <p class="stitle-article-norm">Entry into force and date of application</p>
   <p class="norm">1.&nbsp;&nbsp;This Regulation shall enter into force on the twentieth day following that of its publication in the <span class="italics">Official Journal of the European Union</span>.</p>
   <p class="norm">2.&nbsp;&nbsp;It shall apply from 26 May 2020.</p>
   <p class="norm">3.&nbsp;&nbsp;By way of derogation from paragraph&nbsp;2:</p>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(a)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">Articles&nbsp;35 to 50 shall apply from 26 
November 2017. However, from that date until 26 May 2020, the 
obligations on notified bodies pursuant to Articles&nbsp;35 to 50 shall 
apply only to those bodies which submit an application for designation 
in accordance with [Article&nbsp;38](../notified bodiesArticle 38 - Application by conformity assessment bodies for designation.md);</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(b)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">Articles&nbsp;101 and 103 shall apply from 26 November 2017;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(c)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">[Article&nbsp;102](../cooperation between memberstates  medical device coordination group expert laboratories expert panels  and device registersArticle 102 - Cooperation.md) shall apply from 26 May 2018;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(d)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">without prejudice to the obligations on the 
Commission pursuant to [[[Article&nbsp;34](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 34 - Functionality of Eudamed.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 34 - Functionality of Eudamed.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 34 - Functionality of Eudamed.md), where, due to circumstances that
 could not reasonably have been foreseen when drafting the plan referred
 to in [[[Article&nbsp;34](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 34 - Functionality of Eudamed.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 34 - Functionality of Eudamed.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 34 - Functionality of Eudamed.md)(1), Eudamed is not fully functional on 
26&nbsp;May 2020, the obligations and requirements that relate to 
Eudamed shall apply from the date corresponding to six&nbsp;months after
 the date of publication of the notice referred to in 
[[[Article&nbsp;34](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 34 - Functionality of Eudamed.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 34 - Functionality of Eudamed.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 34 - Functionality of Eudamed.md)(3). The provisions referred to in the preceding sentence
 are:</p>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[[Article&nbsp;29](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 29 - Registration of devices.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 29 - Registration of devices.md),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;31](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 31 - Registration of manufacturers authorised representatives and importers.md),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;32](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 32 - Summary of safety and clinical performance.md),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;33](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 33 - European database on medical devices.md)(4),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">the second sentence of [Article&nbsp;40](../notified bodiesArticle 40 - Nomination of experts for joint assessment of applications for notification.md)(2),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;42](../notified bodiesArticle 42 - Designation and notification procedure.md)(10),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;43](../notified bodiesArticle 43 - Identification number and list of notified bodies.md)(2),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">the second subparagraph&nbsp;of [Article&nbsp;44](../notified bodiesArticle 44 - Monitoring and reassessment of notified bodies.md)(12),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">points (d) and (e) of [Article&nbsp;46](../notified bodiesArticle 46 - Changes to designations and notifications.md)(7),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;53](../conformity assessmentArticle 53 - Involvement of notified bodies in conformity assessment procedures.md)(2),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;54](../conformity assessmentArticle 54 - Clinical evaluation consultation procedure for certain class III and class IIb devices.md)(3),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;55](../conformity assessmentArticle 55 - Mechanism for scrutiny of conformity assessments of certain class III and class IIb devices.md)(1),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">Articles&nbsp;70 to 77,</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">paragraphs 1 to 13 of [[[Article&nbsp;78](../clinical evaluation and clinical investigationsArticle 78 - Coordinated assessment procedure for clinical investigations.md)](../clinical evaluation and clinical investigationsArticle 78 - Coordinated assessment procedure for clinical investigations.md)](../clinical evaluation and clinical investigationsArticle 78 - Coordinated assessment procedure for clinical investigations.md),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">Articles&nbsp;79 to 82,</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;86](../postmarket surveillanceArticle 86 - Periodic safety update report.md)(2),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">Articles&nbsp;87 and 88,</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[[Article&nbsp;89](../vigilanceArticle 89 - Analysis of serious incidents and field safety corrective actions.md)](../vigilanceArticle 89 - Analysis of serious incidents and field safety corrective actions.md)(5) and (7), and the third subparagraph&nbsp;of [[Article&nbsp;89](../vigilanceArticle 89 - Analysis of serious incidents and field safety corrective actions.md)](../vigilanceArticle 89 - Analysis of serious incidents and field safety corrective actions.md)(8),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;90](../vigilanceArticle 90 - Analysis of vigilance data.md),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;93](../market surveillanceArticle 93 - Market surveillance activities.md)(4), (7) and (8),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;95](../market surveillanceArticle 95 - Procedure for dealing with devices presenting an unacceptable risk to health and safety.md)(2) and (4),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">the last sentence of [Article&nbsp;97](../market surveillanceArticle 97 - Other noncompliance.md)(2),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">[Article&nbsp;99](../market surveillanceArticle 99 - Good administrative practice.md)(4),</div>
            </div>
         </div>
         <div class="grid-container grid-list">
            <div class="list grid-list-column-1">
               <span>—&nbsp;</span>
            </div>
            <div class="grid-list-column-2">
               <div class="list">the second sentence of the first subparagraph&nbsp;of [[Article&nbsp;120](../final provisionsArticle 120 - Transitional provisions.md)](../final provisionsArticle 120 - Transitional provisions.md)(3).</div>
            </div>
         </div>
         <p class="list">Until Eudamed is fully functional, the 
corresponding provisions of Directives&nbsp;90/385/EEC and 93/42/EEC 
shall continue to apply for the purpose of meeting the obligations laid 
down in the provisions listed in the first paragraph&nbsp;of this point 
regarding exchange of information including, and in particular, 
information regarding vigilance reporting, clinical investigations, 
registration of devices and economic operators, and certificate 
notifications.</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(e)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">[[Article&nbsp;29](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 29 - Registration of devices.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 29 - Registration of devices.md)(4) and [Article&nbsp;56](../conformity assessmentArticle 56 - Certificates of conformity.md)(5) shall apply from 18 months after the later of the dates referred to in point&nbsp;(d);</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(f)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">for implantable devices and for class III 
devices [[[[Article&nbsp;27](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)(4) shall apply from 26&nbsp;May 2021. For 
class&nbsp;IIa and class&nbsp;IIb devices [[[[Article&nbsp;27](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)(4) shall apply
 from 26&nbsp;May 2023. For class I devices [[[[Article&nbsp;27](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)(4) shall 
apply from 26&nbsp;May 2025;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(g)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">for reusable devices that shall bear the UDI 
carrier on the device itself, [[[[Article&nbsp;27](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)](../identification and traceability of devices  registration of devices and of economic operators summary of safety  and clinical performance european database on medical devicesArticle 27 - Unique Device Identification system.md)(4) shall apply from two 
years after the date referred to in point&nbsp;(f) of this 
paragraph&nbsp;for the respective class of devices in that point;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(h)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">The procedure set out in [[[Article&nbsp;78](../clinical evaluation and clinical investigationsArticle 78 - Coordinated assessment procedure for clinical investigations.md)](../clinical evaluation and clinical investigationsArticle 78 - Coordinated assessment procedure for clinical investigations.md)](../clinical evaluation and clinical investigationsArticle 78 - Coordinated assessment procedure for clinical investigations.md) shall apply from 26 May 2027, without prejudice to [[[Article&nbsp;78](../clinical evaluation and clinical investigationsArticle 78 - Coordinated assessment procedure for clinical investigations.md)](../clinical evaluation and clinical investigationsArticle 78 - Coordinated assessment procedure for clinical investigations.md)](../clinical evaluation and clinical investigationsArticle 78 - Coordinated assessment procedure for clinical investigations.md)(14);</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(i)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">[[Article&nbsp;120](../final provisionsArticle 120 - Transitional provisions.md)](../final provisionsArticle 120 - Transitional provisions.md)(12) shall apply from 26 May 2019.</p>
      </div>
 </div>